HK-II is upregulated in cancer cells and can be selectively inhibited by 2-deoxyglucose (2-DG), a glucose analog that, once phosphorylated, accumulates as 2-deoxyglucose-6-phosphate and inhibits HK-II activity. The gene discussed is HK2; the disease is cancer.